EUVIMEDEUVIMED entdecken
Open Access

CT findings in biomass smoke-associated interstitial lung disease: A retrospective analysis

Jesse Gordon Bendetson, Helen Tran, Mina Sophia Kamangar, Keren Fogelfeld, Cecilia Matilda Jude, Nader Kamangar

Journal of Clinical Imaging Science · 28.04.2026 · 16 · 17

DOI: 10.25259/jcis_225_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Imaging Science, online erschienen am 28.04.2026. Verfasst von Jesse Gordon Bendetson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Olive View-UCLA Medical Center, California, United States. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Household air pollution from biomass fuel combustion remains a major global health burden, affecting nearly 3 billion people worldwide. Although biomass smoke exposure is a recognized risk factor for chronic airway disease, its role in interstitial lung disease (ILD) is less well defined, and characteristic CT features have not been systematically described in patients without coexisting chronic obstructive pulmonary disease (COPD). Material and Methods: We conducted a retrospective review of 23 patients with biomass smoke exposure and radiographic evidence of ILD, excluding those with alternative ILD etiologies or pre-existing COPD. CT scans were independently assessed by a thoracic radiologist and two pulmonologists for predominant patterns, distributions, and additional findings, with consensus classification. We report proportions with 95% confidence intervals (CIs) and performed exploratory Spearman correlation to assess associations between selected CT features.

Results

The cohort (mean age 71.7 years; all females; 96% born outside the United States) most commonly demonstrated reticulation (16/23, 70%; 95% CI, 49–84%), ground-glass opacities (GGO) (15/23, 65%; 95% CI, 45–81%), mosaic attenuation (15/23, 65%; 95% CI, 45–81%), and bronchial wall thickening (14/23, 61%; 95% CI, 41–78%). Abnormalities were typically patchy (18/23, 78%; 95% CI, 58–90%) and peribronchial (13/23, 57%; 95% CI, 37–74%), without consistent apical or basal predominance. Traction bronchiectasis occurred in 12/23 (52%; 95% CI, 33–71%) and lymphadenopathy in 9/23 (39%; 95% CI, 22–59%). Honeycombing (5/23, 22%; 95% CI, 10–42%), centrilobular emphysema (4/23, 17%; 95% CI, 7–37%), nodules (3/23, 13%; 95% CI, 5–32%), cysts (2/23, 9%; 95% CI, 2–27%), tree-in-bud opacities (2/23, 9%; 95% CI, 2–27%), and centrilobular nodularity (1/23, 4%; 95% CI, 1–21%) were uncommon. Exploratory Spearman analyses showed strong associations between mosaic attenuation and bronchial wall thickening (ρ = 0.91) and between peribronchial distribution and mosaic attenuation (ρ = 0.83), with additional positive correlations between mosaic attenuation and bronchiectasis (ρ = 0.70), peribronchial distribution and bronchial wall thickening (ρ = 0.73), bronchial wall thickening and bronchiectasis (ρ = 0.77), bronchiectasis and traction bronchiectasis (ρ = 0.57), and reticulation and traction bronchiectasis (ρ = 0.69). Exploratory Spearman correlation analyses showed strong associations between mosaic attenuation and bronchial wall thickening (ρ = 0.91) and between peribronchial distribution and mosaic attenuation (ρ = 0.83), with additional positive correlations between mosaic attenuation and bronchiectasis (ρ = 0.70), peribronchial distribution and bronchial wall thickening (ρ = 0.73), bronchial wall thickening and bronchiectasis (ρ = 0.77), bronchiectasis and traction bronchiectasis (ρ = 0.57), and reticulation and traction bronchiectasis (ρ = 0.69).

Conclusion

Biomass smoke-associated ILD demonstrates a distinctive CT pattern characterized by reticulation, GGOs, and mosaic attenuation with patchy and peribronchial distribution and no clear zonal predominance. Unlike hypersensitivity pneumonitis, it lacks centrilobular nodularity. Compared with idiopathic pulmonary fibrosis (IPF), it shows less extensive subpleural honeycombing, more peribronchial involvement, and no consistent basal predominance. These distinctions may improve recognition of biomass smoke-associated ILD in exposed patients. Further prospective studies are needed to validate these findings and clarify their prognostic significance.

Schlagwörter

Stichwörter der Autor:innen

Biomass smokeComputed tomographyHousehold air pollutionInterstitial lung diseasePulmonary fibrosis

Autor:innen und Institutionen

  • Department of Medicine, Olive View-UCLA Medical Center, California, United States.
  • Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, David Geffen School of Medicine at UCLA Olive View-UCLA Medical Center, California, United States.
  • Department of Radiology, David Geffen School of Medicine, Greater Los Angeles Veterans Affairs Medical Center, California, United States.

Zitieren

APA

Bendetson, J. G., Tran, H., Kamangar, M. S., Fogelfeld, K., Jude, C. M., & Kamangar, N. (2026). CT findings in biomass smoke-associated interstitial lung disease: A retrospective analysis. Journal of Clinical Imaging Science, 16, 17. https://doi.org/10.25259/jcis_225_2025

Vancouver

Bendetson JG, Tran H, Kamangar MS, Fogelfeld K, Jude CM, Kamangar N. CT findings in biomass smoke-associated interstitial lung disease: A retrospective analysis. Journal of Clinical Imaging Science. 2026;16:17. doi:10.25259/jcis_225_2025

BibTeX
@article{Bendetson2026,
  author = {Bendetson, Jesse Gordon and Tran, Helen and Kamangar, Mina Sophia and Fogelfeld, Keren and Jude, Cecilia Matilda and Kamangar, Nader},
  title = {CT findings in biomass smoke-associated interstitial lung disease: A retrospective analysis},
  journal = {Journal of Clinical Imaging Science},
  year = {2026},
  volume = {16},
  pages = {17},
  doi = {10.25259/jcis_225_2025}
}
Kostenlos starten →